Aurinia Pharmaceuticals
Earnings Date & Report
Last updated:
Aurinia Pharmaceuticals’s last earnings date was on 10 Nov 2020. It reported its quarterly earnings per share (EPS) reaching -$0.28, falling behind the estimated value of -$0.22 by $0.06. The company’s quarterly earnings decreased by 87.39% to 29K US dollars compared to the same quarter of the previous year. Over the last year, Aurinia Pharmaceuticals’s earnings per share have dropped by 33.33%.
Aurinia Pharmaceuticals stock Earnings report, Estimates & History
| 2016-03-18 | -0.13 | -0.13 |
|---|---|---|
| 2016-05-11 | -0.14 | -0.13 |
| 2016-08-05 | -0.08 | -0.1 |
| 2016-11-04 | -0.15 | -0.21 |
| 2017-03-09 | -0.12 | -0.21 |
| 2017-05-15 | -0.11 | -0.92 |
| 2017-08-10 | -0.13 | -0.03 |
| 2017-11-14 | -0.12 | -0.16 |
| 2018-03-15 | -0.15 | -0.04 |
| 2018-05-10 | -0.16 | -0.18 |
| 2018-08-09 | -0.15 | -0.19 |
| 2018-11-08 | -0.16 | -0.21 |
| 2019-03-19 | -0.15 | -0.17 |
| 2019-05-14 | -0.14 | -0.14 |
| 2019-08-06 | -0.14 | -0.17 |
| 2019-11-14 | -0.16 | -0.21 |
| 2020-03-05 | -0.18 | -0.78 |
| 2020-05-14 | -0.24 | -0.15 |
| 2020-08-11 | -0.25 | -0.26 |
| 2020-11-10 | -0.22 | -0.28 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Aurinia Pharmaceuticals stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 10 Nov 2020 | Missed | -$0.22 | -$0.28 | N/A | 29K | |
| 11 Aug 2020 | Missed | -$0.25 | -$0.26 | 27.88K | 29K | |
| 14 May 2020 | Beat | -$0.24 | -$0.15 | 46.4K | 30K | |
| 5 Mar 2020 | Missed | -$0.18 | -$0.78 | 6.92K | 29K | |
| 14 Nov 2019 | Missed | -$0.16 | -$0.21 | 22.09K | 230K | |
| 6 Aug 2019 | Missed | -$0.14 | -$0.17 | 189.41K | 29K | |
| 14 May 2019 | Matched | -$0.14 | -$0.14 | 29K | 30K | |
| 19 Mar 2019 | Missed | -$0.15 | -$0.17 | 26.47K | 29K | |
| 8 Nov 2018 | Missed | -$0.16 | -$0.21 | 22.09K | 375K | |
| 9 Aug 2018 | Missed | -$0.15 | -$0.19 | 296.05K | 29K | |
| 10 May 2018 | Missed | -$0.16 | -$0.18 | 25.77K | 30K | |
| 15 Mar 2018 | Beat | -$0.15 | -$0.04 | 112.5K | 31K | |
| 14 Nov 2017 | Missed | -$0.12 | -$0.16 | 23.25K | 29K | |
| 10 Aug 2017 | Beat | -$0.13 | -$0.03 | 125.66K | 329K | |
| 15 May 2017 | Missed | -$0.11 | -$0.92 | 39.33K | 31K | |
| 9 Mar 2017 | Missed | -$0.12 | -$0.21 | 17.71K | 30K | |
| 4 Nov 2016 | Missed | -$0.15 | -$0.21 | 21.42K | 31K | |
| 5 Aug 2016 | Missed | -$0.08 | -$0.1 | 24.8K | 55K | |
| 11 May 2016 | Beat | -$0.14 | -$0.13 | 59.23K | 57K | |
| 18 Mar 2016 | Matched | -$0.13 | -$0.13 | 57K | 57K | |
Aurinia Pharmaceuticals Earnings report FAQs
When is Aurinia Pharmaceuticals's next Earnings date?
The company has not set the next earnings date yet. The latest Aurinia Pharmaceuticals's earnings date was on 14 Nov 2019.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.